Literature DB >> 23288357

A global view of Hsp90 functions.

Gabriela Chiosis1, Chad A Dickey, Jill L Johnson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23288357      PMCID： PMC4004347          DOI： 10.1038/nsmb.2481

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN： 1545-9985            Impact factor:   15.369


× No keyword cloud information.
  13 in total

1.  Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90.

Authors:  Kamalika Moulick; James H Ahn; Hongliang Zong; Anna Rodina; Leandro Cerchietti; Erica M Gomes DaGama; Eloisi Caldas-Lopes; Kristin Beebe; Fabiana Perna; Katerina Hatzi; Ly P Vu; Xinyang Zhao; Danuta Zatorska; Tony Taldone; Peter Smith-Jones; Mary Alpaugh; Steven S Gross; Nagavarakishore Pillarsetty; Thomas Ku; Jason S Lewis; Steven M Larson; Ross Levine; Hediye Erdjument-Bromage; Monica L Guzman; Stephen D Nimer; Ari Melnick; Len Neckers; Gabriela Chiosis
Journal:  Nat Chem Biol       Date:  2011-09-25       Impact factor: 15.040

2.  Dynamic tyrosine phosphorylation modulates cycling of the HSP90-P50(CDC37)-AHA1 chaperone machine.

Authors:  Wanping Xu; Mehdi Mollapour; Chrisostomos Prodromou; Suiquan Wang; Bradley T Scroggins; Zach Palchick; Kristin Beebe; Marco Siderius; Min-Jung Lee; Anthony Couvillon; Jane B Trepel; Yoshihiko Miyata; Robert Matts; Len Neckers
Journal:  Mol Cell       Date:  2012-06-21       Impact factor: 17.970

3.  Systematic identification of the HSP90 candidate regulated proteome.

Authors:  Zhixiang Wu; Amin Moghaddas Gholami; Bernhard Kuster
Journal:  Mol Cell Proteomics       Date:  2012-02-14       Impact factor: 5.911

4.  Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition.

Authors:  Mikko Taipale; Irina Krykbaeva; Martina Koeva; Can Kayatekin; Kenneth D Westover; Georgios I Karras; Susan Lindquist
Journal:  Cell       Date:  2012-08-31       Impact factor: 41.582

5.  From a ratchet mechanism to random fluctuations evolution of Hsp90's mechanochemical cycle.

Authors:  Christoph Ratzke; Minh N T Nguyen; Matthias P Mayer; Thorsten Hugel
Journal:  J Mol Biol       Date:  2012-08-06       Impact factor: 5.469

6.  Exploiting cancer cell vulnerabilities to develop a combination therapy for ras-driven tumors.

Authors:  Thomas De Raedt; Zandra Walton; Jessica L Yecies; Danan Li; Yimei Chen; Clare F Malone; Ophélia Maertens; Seung Min Jeong; Roderick T Bronson; Valerie Lebleu; Raghu Kalluri; Emmanuel Normant; Marcia C Haigis; Brendan D Manning; Kwok-Kin Wong; Kay F Macleod; Karen Cichowski
Journal:  Cancer Cell       Date:  2011-09-13       Impact factor: 31.743

7.  Phosphoproteome dynamics reveal heat-shock protein complexes specific to the Leishmania donovani infectious stage.

Authors:  Miguel A Morales; Reiko Watanabe; Mariko Dacher; Philippe Chafey; José Osorio y Fortéa; David A Scott; Stephen M Beverley; Gabi Ommen; Joachim Clos; Sonia Hem; Pascal Lenormand; Jean-Claude Rousselle; Abdelkader Namane; Gerald F Späth
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-19       Impact factor: 11.205

8.  Dynamics of the regulation of Hsp90 by the co-chaperone Sti1.

Authors:  Chung-Tien Lee; Christian Graf; Franz J Mayer; Sebastian M Richter; Matthias P Mayer
Journal:  EMBO J       Date:  2012-02-21       Impact factor: 11.598

9.  Hsp90 globally targets paused RNA polymerase to regulate gene expression in response to environmental stimuli.

Authors:  Ritwick Sawarkar; Cem Sievers; Renato Paro
Journal:  Cell       Date:  2012-05-11       Impact factor: 41.582

10.  An interaction network predicted from public data as a discovery tool: application to the Hsp90 molecular chaperone machine.

Authors:  Pablo C Echeverría; Andreas Bernthaler; Pierre Dupuis; Bernd Mayer; Didier Picard
Journal:  PLoS One       Date:  2011-10-11       Impact factor: 3.240
View more
  22 in total

1.  A pyrrole-based natural small molecule mitigates HSP90 expression in MDA-MB-231 cells and inhibits tumor angiogenesis in mice by inactivating HSF-1.

Authors:  K C Rashmi; H S Atreya; M Harsha Raj; Bharathi P Salimath; H S Aparna
Journal:  Cell Stress Chaperones       Date:  2017-07-17       Impact factor: 3.667

2.  Hsp90 inhibition destabilizes Ezh2 protein in alloreactive T cells and reduces graft-versus-host disease in mice.

Authors:  Qingrong Huang; Shan He; Yuanyuan Tian; Yuting Gu; Pan Chen; Changhong Li; Jiefang Huang; Yongnian Liu; Hongshuang Yu; Min Jin; Shaoyan Hu; Qing Tong; Anqi Ma; Jian Jin; Elizabeth Hexner; Henry Fung; Ran Reshef; Yi Zhang; Yanyun Zhang
Journal:  Blood       Date:  2017-02-28       Impact factor: 22.113

Review 3.  Modulation of Molecular Chaperones in Huntington's Disease and Other Polyglutamine Disorders.

Authors:  Sara D Reis; Brígida R Pinho; Jorge M A Oliveira
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

4.  Experimental and structural testing module to analyze paralogue-specificity and affinity in the Hsp90 inhibitors series.

Authors:  Tony Taldone; Pallav D Patel; Maulik Patel; Hardik J Patel; Christopher E Evans; Anna Rodina; Stefan Ochiana; Smit K Shah; Mohammad Uddin; Daniel Gewirth; Gabriela Chiosis
Journal:  J Med Chem       Date:  2013-08-21       Impact factor: 7.446

5.  Cytosolic PKM2 stabilizes mutant EGFR protein expression through regulating HSP90-EGFR association.

Authors:  Y-C Yang; T-Y Cheng; S-M Huang; C-Y Su; P-W Yang; J-M Lee; C-K Chen; M Hsiao; K-T Hua; M-L Kuo
Journal:  Oncogene       Date:  2015-10-26       Impact factor: 9.867

6.  The Development of Hsp90β-Selective Inhibitors to Overcome Detriments Associated with pan-Hsp90 Inhibition.

Authors:  Sanket J Mishra; Weiya Liu; Kristin Beebe; Monimoy Banerjee; Caitlin N Kent; Vitumbiko Munthali; John Koren; John A Taylor; Leonard M Neckers; Jeffrey Holzbeierlein; Brian S J Blagg
Journal:  J Med Chem       Date:  2021-01-11       Impact factor: 7.446

7.  Okicamelliaside targets the N-terminal chaperone pocket of HSP90 disrupts the chaperone protein interaction of HSP90-CDC37 and exerts antitumor activity.

Authors:  Chuan-Jing Cheng; Kai-Xin Liu; Man Zhang; Fu-Kui Shen; Li-Li Ye; Wen-Bo Wu; Xiao-Tao Hou; Er-Wei Hao; Yuan-Yuan Hou; Gang Bai
Journal:  Acta Pharmacol Sin       Date:  2021-07-29       Impact factor: 6.150

8.  Screening of multiple myeloma by polyclonal rabbit anti-human plasmacytoma cell immunoglobulin.

Authors:  Bo Mu; Huan Zhang; Xiaoming Cai; Junbao Yang; Yuewu Shen; Baofeng Chen; Suhua Liang
Journal:  PLoS One       Date:  2013-04-01       Impact factor: 3.240

Review 9.  A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care.

Authors:  Richard E Kast; John A Boockvar; Ansgar Brüning; Francesco Cappello; Wen-Wei Chang; Boris Cvek; Q Ping Dou; Alfonso Duenas-Gonzalez; Thomas Efferth; Daniele Focosi; Seyed H Ghaffari; Georg Karpel-Massler; Kirsi Ketola; Alireza Khoshnevisan; Daniel Keizman; Nicolas Magné; Christine Marosi; Kerrie McDonald; Miguel Muñoz; Ameya Paranjpe; Mohammad H Pourgholami; Iacopo Sardi; Avishay Sella; Kalkunte S Srivenugopal; Marco Tuccori; Weiguang Wang; Christian R Wirtz; Marc-Eric Halatsch
Journal:  Oncotarget       Date:  2013-04

10.  Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer's Disease.

Authors:  Angel Agis-Torres; Monica Sölhuber; Maria Fernandez; J M Sanchez-Montero
Journal:  Curr Neuropharmacol       Date:  2014-01       Impact factor: 7.363
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.